Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA 290 effects on hypoxic ventilatory response and pain in healthy volunteers
NL-OMON23515Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of cibinetide (3 arms), sponsored by Leiden University Medical Center. Primary endpoints: Ventilatory response to isocapnic hypoxia, Tricuspid valve gradient during hypoxia and 1 more. Started Oct 2011; status: active, not recruiting.
02
Drugs
cibinetide
Beyond the preview
Go deeper on NL-OMON23515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23515.